Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Published : Aug-2017

No. of Pages : 132

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, Australia 11
3.1 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2023 11
3.2 Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13
3.3 Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14
3.4 Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
3.5 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2016 16
3.6 Drug Delivery Devices Market, Australia, Revenue ($m), 2016-2023 18
3.7 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20
3.8 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2016 22
3.9 Drug Delivery Devices Market, Australia, Volume (Units), 2016-2023 24
3.10 Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), 2016 26
4 Central Venous Catheters Market, Australia 28
4.1 Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28
4.2 Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
4.3 Central Venous Catheters Market, Australia, Revenue ($m), 2009-2016 30
4.4 Central Venous Catheters Market, Australia, Revenue ($m), 2016-2023 32
4.5 Central Venous Catheters Market, Australia, Volume (Units), 2009-2016 34
4.6 Central Venous Catheters Market, Australia, Volume (Units), 2016-2023 36
4.7 Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), 2015-2016 38
4.8 Central Venous Catheters Market, Australia, Company Share by Revenue ($m), 2016 39
5 Infusion Systems Market, Australia 41
5.1 Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41
5.2 Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
5.3 Infusion Systems Market, Australia, Revenue ($m), 2009-2016 43
5.4 Infusion Systems Market, Australia, Revenue ($m), 2016-2023 45
5.4.1 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 47
5.4.2 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 49
5.4.3 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 51
5.4.4 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 53
5.5 Infusion Systems Market, Australia, Volume (Units), 2009-2016 55
5.6 Infusion Systems Market, Australia, Volume (Units), 2016-2023 57
5.6.1 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 59
5.6.2 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 61
5.6.3 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 63
5.6.4 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 65
5.7 Infusion Systems Market, Australia, Distribution Share by Revenue ($m), 2015-2016 67
5.8 Infusion Systems Market, Australia, Company Share by Revenue ($m), 2016 68
6 Needle Free Injections Market, Australia 70
6.1 Needle Free Injections Market, Australia, Revenue ($m), 2009-2016 70
6.2 Needle Free Injections Market, Australia, Revenue ($m), 2016-2023 71
6.3 Needle Free Injections Market, Australia, Volume (Units), 2009-2016 72
6.4 Needle Free Injections Market, Australia, Volume (Units), 2016-2023 73
6.5 Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), 2015-2016 74
6.6 Needle Free Injections Market, Australia, Company Share by Revenue ($m), 2016 75
7 Metered Dose Inhaler Devices Market, Australia 77
7.1 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2009-2016 77
7.2 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2016-2023 78
7.3 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2009-2016 79
7.4 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2016-2023 80
7.5 Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016 81
7.6 Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), 2016 82
8 Overview of Key Companies in Australia, Drug Delivery Devices Market 84
8.1 Teleflex Inc 84
8.1.1 Company Overview 84
8.2 GlaxoSmithKline Plc 84
8.2.1 Company Overview 84
8.3 AstraZeneca Plc 84
8.3.1 Company Overview 84
8.4 Becton Dickinson and Co 84
8.4.1 Company Overview 84
8.5 Boehringer Ingelheim GmbH 85
8.5.1 Company Overview 85
8.6 Baxter International Inc 85
8.6.1 Company Overview 85
8.7 Fresenius Kabi AG 85
8.7.1 Company Overview 85
8.8 Pfizer Inc 86
8.8.1 Company Overview 86
8.9 B. Braun Melsungen AG 86
8.9.1 Company Overview 86
8.10 Smiths Medical 86
8.10.1 Company Overview 86
8.11 Merck & Co Inc 87
8.11.1 Company Overview 87
8.12 Hospira Inc 87
8.12.1 Company Overview 87
8.13 Terumo Corp 87
8.13.1 Company Overview 87
8.14 Nipro Corp 87
8.14.1 Company Overview 87
8.15 Medtronic plc 88
8.19.1 Company Overview 88
9 Drug Delivery Devices Market Pipeline Products 89
10 Financial Deals Landscape 94
10.1 Asset Transactions 94
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
10.2 Debt Offerings 96
10.2.1 Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96
10.3 Equity Offerings 97
10.3.1 Suda Raises USD1.1 Million in Private Placement of Shares 97
10.3.2 Admedus Raises USD7.5 Million in Private Placement of Shares 99
10.3.3 Admedus Raises USD4 Million in Rights Offering of Shares 100
10.4 Partnerships 101
10.4.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101
10.4.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102
10.4.3 Pfizer Terminates its Licensing Agreement with pSivida 104
10.4.4 Bayer Enters into Licensing Agreement with DelSiTech 105
10.4.5 BioCorRx Enters into Licensing Agreement with Therakine 106
11 Recent Developments 107
11.1 Corporate Communications 107
11.1.1 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer 107
11.1.2 May 23, 2017: Analytica: Appointment of Dr. Peter B. Corr as Director 107
11.1.3 Apr 21, 2017: Phosphagenics Announces Transition of Chairman of the Board 108
11.1.4 Apr 04, 2017: GSK responds to Cyclone Debbie 109
11.1.5 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 109
11.1.6 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 110
11.1.7 Dec 12, 2016: Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option 111
11.1.8 Dec 08, 2016: Acrux Announces Director Resignation 112
11.1.9 Oct 17, 2016: Medrobotics Corporation Receives Expanded CE Mark for Flex Robotic System 112
11.1.10 Sep 25, 2016: Admedus Strengthens Management Team 113
11.1.11 Sep 15, 2016: Anne Belcher to succeed Geoff McDonald as GSK Australia general manager 113
11.1.12 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 114
11.2 Financial Announcements 114
11.2.1 May 02, 2017: GSK Australia Reports 2016 results to ASIC 114
11.2.2 Apr 28, 2017: Clinuvel Pharmaceuticals: Appendix 4C - Quarterly report 115
11.2.3 Feb 28, 2017: Phosphagenics Full Year Financial Results 116
11.2.4 Feb 24, 2017: Admedus Announces Half Yearly Report 117
11.2.5 Feb 23, 2017: ITL Profit Doubles In Half Year 2016/2017 Results 118
11.2.6 Feb 20, 2017: Medical Developments Reports Revenue Of AUD8m In H1 Fiscal 2017 118
11.2.7 Oct 31, 2016: Suda: Appendix 4C For First Quarter Fy 2017 119
11.2.8 Oct 28, 2016: Analytica: Appendix 4C - Quarterly Cash Flow Report 119
11.2.9 Aug 31, 2016: Analytica Announces 2016 Full Year Results 119
11.2.10 Aug 24, 2016: Acrux: Financial Report for the year ended 30 June 2016 120
11.2.11 Jul 20, 2016: Admedus Announces Financial Report 121
11.3 Legal And Regulatory 122
11.3.1 May 29, 2017: Phosphagenic - Mylan Arbitration Update - expert report on quantum of damages claimed filed 122
11.3.2 Jan 20, 2017: Change of Registered Office and Principal Place of Business 122
11.3.3 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 122
11.4 Other Significant Developments 123
11.4.1 Apr 26, 2017: Axiron Net Sales, quarter to March 2017 123
11.4.2 Apr 13, 2017: PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest 123
11.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 124
11.4.4 Jan 31, 2017: Analytica Releases Quarterly Cash Flow Report 125
11.4.5 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 125
11.4.6 Oct 28, 2016: Starpharma Quarterly Cashflow Report 126
11.5 Product News 127
11.5.1 Oct 26, 2016: Starpharma to present at US Drug Delivery Conference 127
12 Appendix 128
12.1 Research Methodology 129
12.1.1 Coverage 129
12.1.2 Secondary Research 129
12.1.3 Primary Research 130
12.1.4 Company Share Analysis 130
12.1.5 Distribution Share Analysis 130
12.1.6 Benchmarking 131
12.2 GlobalData Consulting 131
12.3 Contact Us 132
12.4 Disclaimer 132

1.1 List of Tables
Table 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 12
Table 2: Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14
Table 3: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
Table 4: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Table 6: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 21
Table 7: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 23
Table 8: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 25
Table 9: Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 27
Table 10: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
Table 11: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 31
Table 12: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Table 13: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 35
Table 14: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 37
Table 15: Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
Table 16: Central Venous Catheters Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 40
Table 17: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
Table 18: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 44
Table 19: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Table 20: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 48
Table 21: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 50
Table 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Table 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 54
Table 24: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 56
Table 25: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 58
Table 26: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 60
Table 27: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 62
Table 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 64
Table 29: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 66
Table 30: Infusion Systems Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 67
Table 31: Infusion Systems Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 69
Table 32: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70
Table 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Table 34: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72
Table 35: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73
Table 36: Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 74
Table 37: Needle Free Injections Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 76
Table 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77
Table 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Table 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79
Table 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80
Table 42: Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 81
Table 43: Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 83
Table 44: Drug Delivery Devices Market Pipeline Products 89
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
Table 46: Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96
Table 47: Suda Raises USD1.1 Million in Private Placement of Shares 97
Table 48: Admedus Raises USD7.5 Million in Private Placement of Shares 99
Table 49: Admedus Raises USD4 Million in Rights Offering of Shares 100
Table 50: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101
Table 51: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102
Table 52: Pfizer Terminates its Licensing Agreement with pSivida 104
Table 53: Bayer Enters into Licensing Agreement with DelSiTech 105
Table 54: BioCorRx Enters into Licensing Agreement with Therakine 106

1.2 List of Figures
Figure 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 11
Figure 2: Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13
Figure 3: Drug Delivery Devices Market, Australia, Category Contribution (%), 2016 14
Figure 4: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
Figure 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 16
Figure 6: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Figure 7: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20
Figure 8: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 22
Figure 9: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 24
Figure 10: Drug Delivery Devices Market, Australia, Company Share (%) 2016 26
Figure 11: Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28
Figure 12: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
Figure 13: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 30
Figure 14: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 32
Figure 15: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 34
Figure 16: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 36
Figure 17: Central Venous Catheters Market, Australia, Company Share (%) 2016 39
Figure 18: Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41
Figure 19: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
Figure 20: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 43
Figure 21: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 45
Figure 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 47
Figure 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 49
Figure 24: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 51
Figure 25: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Figure 26: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 55
Figure 27: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 57
Figure 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 59
Figure 29: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 61
Figure 30: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 63
Figure 31: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 65
Figure 32: Infusion Systems Market, Australia, Company Share (%) 2016 68
Figure 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70
Figure 34: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Figure 35: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72
Figure 36: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73
Figure 37: Needle Free Injections Market, Australia, Company Share (%) 2016 75
Figure 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77
Figure 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Figure 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79
Figure 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80
Figure 42: Metered Dose Inhaler Devices Market, Australia, Company Share (%) 2016 82

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027